Home diagnostics Visby Medical offers true PCR results in 30 minutes with an instrument-free, palm-sized test, presenting a compelling opportunity to position at-home infectious disease testing and complementary telehealth services to consumers seeking rapid, private results.

Women's health focus The over-the-counter Women’s Sexual Health Test enables private, at-home testing without a prescription, supported by an app and telehealth access for same-day treatment, signaling growth potential in consumer-led women’s health diagnostics.

Strategic partnerships Recent collaborations with Hellowisp for at-home FDA-authorized STI testing and with Watchmaker Genomics for respiratory pathogen tests at home indicate a proven path to expand product adoption via co-marketing, distribution, and integrated care ecosystems.

Growth funding A $55M funding round led by Catalio Capital Management underscores investor confidence and potential for scaling manufacturing, regulatory advancement, and market expansion, including consumer channels and telehealth integrations.

Technology enabled Leveraging a software-enabled workflow with an app, cloud tools, and a consumer-friendly platform, Visby can cross-sell or bundle tests, telehealth referrals, and data-driven support services to expand appointment-like revenue within home diagnostics.